Belocura, Pedro, JR.. T.
HRN: 22-07-74 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2022
CEFTRIAXONE 1G (VIAL)
10/21/2022
10/27/2022
IVTT
2g LD; 1g OD
Q24
Cholangitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Wrong Dose
Overall appropriateness: No Wrong Dose